Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
U.S. Representative David Trone (D-Md.), and Reps. Guy Reschenthaler (R-Pa.), Teresa Leger Fernandez (D-N.M.), and David McKinley (R-W.V.) are introducing the bipartisan Opioid Patients’ Right to Know Act in an effort to help reduce the prevalence of opioid addiction across U.S. The new proposal is based on the successful inception of the New Jersey Patient
State program will install life-saving overdose reversal medication boxes in clinics.
Herbert Washington files a racial discrimination lawsuit against McDonald’s.
PTP asks to join Peninsula Township as a co-defendant in WOMP’s case.
FDA takes issue with Dsuvia marketing.
DOJ indicts Japanese company for dumping wastewater without following regulations.
Senators draft new legislation after spending seven months trying to get answers.
Pressure mounts to deregulate buprenorphine.
Sony is joining other big names in the gaming industry in being on the receiving end of a lawsuit alleging its DualSense controllers are drifting due to a hardware defect. The newest class action has been filed by law firm Chimicles Schwartz Kriner & Donaldson-Smith LLP in the U.S. District Court for the Southern District
Mayo Clinic researchers report that, although on the decline, opioids were being given for treatment of diabetic neuropathy in recent years.